Dr Ling Su to head DIA board

HORSHAM, PA – The Drug Information Association (DIA) has announced the appointment of Dr Su Ling as the president of its Board of Directors.

DIA is a neutral, global, professional, member-driven association of nearly 18,000 professionals involved in the discovery, development, and life cycle management of pharmaceuticals, biotechnology, medical devices, and related medical products.

Dr Su is senior vice president and head of Development Greater China Region of Beijing Novartis Pharma Co., Ltd. He is also an adjunct professor in the School of Pharmacy at Fudan University in Shanghai.

His professional experience involves 20 years in the areas of regulatory affairs, clinical research and development, R&D strategies, pharmaco-vigilance, pharmaco-epidemiology, and outcomes research.

“Through my years of service in the industry, as an active DIA volunteer for 20 years, and now as DIA Board president, I plan on sharing my insight to help DIA and the industry overcome the challenges that we collectively face,” Dr Su said.